Executives On The Move: Comings And Goings This Week At Sosei And Shire, Plus An Upcoming Departure At Ferring
Sosei Group selects a new EVP, CFO and Rare Diseases VP departs Shire for Blueprint Medicines. At Ferring Pharmaceuticals, COO makes known plans to step down.
You may also be interested in...
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
Executives On The Move: CEOs Named At Evolve Biologics, Miragen Therapeutics, Receptor Life Sciences
Chief commercial officer appointed at Moderna.
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.